Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

111.41
Delayed Data
As of Jul 22
 -1.02 / -0.91%
Today’s Change
97.52
Today|||52-Week Range
176.84
-28.86%
Year-to-Date
Why United Therapeutics (UTHR) Might Surprise This Earnings Season
Jul 22 / Zacks.com - Paid Partner Content
3 Biotech Stocks for Conservative Investors
Jul 17 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks That Could Soar Over the Next 12 Months
Jul 19 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close112.43
Today’s open113.00
Day’s range111.29 - 113.43
Volume412,923
Average volume (3 months)700,154
Market cap$5.0B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+8.87%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+13.76%
P/E ratio6.4
Price/Sales5.47
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-0.05-0.05%
OPKOPKO Health Inc+0.08+0.81%
GRFSGrifols SA+0.04+0.24%
NBIXNeurocrine Bioscienc...+0.43+0.88%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$3.10
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts

Partner Offers

Search for Jobs